SCHEMBL4082098

SCHEMBL4082098

CC(CO)=NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5982038 1.00
SCHEMBL15577940 0.85 ALDH1A1 (0.43)
SCHEMBL15577939 0.85 ALDH1A1 (0.43)
SCHEMBL4079399 0.74
SCHEMBL3398785 0.72
SCHEMBL1268269 0.72 ALDH1A1 (1.00)
SCHEMBL17988352 0.72
SCHEMBL9560049 0.72
SCHEMBL6863667 0.72
SCHEMBL15254109 0.72 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117862-B2 Methods of producing molindone and its salts SUPERNUS PHARMACEUTICALS, INC. (US) 2021-09-14 US claimed
US-20200262789-A1 METHODS OF PRODUCING MOLINDONE AND ITS SALTS SUPERNUS PHARMACEUTICALS, INC. (US) 2020-08-20 US claimed
JP-60006651-A None JP disclosed
CN-113321925-B Composition for 3D printing, preparation method thereof, 3D printing method and device 珠海赛纳三维科技有限公司 2022-08-12 CN disclosed
CN-114401722-A Inhibitors of tyrosine kinases 布里奇恩生物科学公司 2022-04-26 CN disclosed
CN-113321925-A Composition for 3D printing, preparation method thereof, 3D printing method and device 珠海赛纳三维科技有限公司 2021-08-31 CN disclosed
JP-2009106923-A CATALYTIC HYDROGENATION METHOD AND NOVEL CATALYST THEREFORE EMMELLEN BIOTECH PHARMACEUTICALS LTD 2009-05-21 JP disclosed
US-20090042888-A1 Prostaglandin endoperoxide H synthase biosynthesis inhibitors BLACK LAWRENCE A 2009-02-12 US disclosed
EP-1735266-A1 PROCESS FOR PREPARATION OF OPTICALLY ACTIVE 1-ERYTHRO-2-AMINO-1-PHENYL-1-PROPANOL Emmellen Biotech Pharmaceuticals Limited (IN) 2006-12-27 EP disclosed
US-7115591-B2 Pyridazinone compounds as cyclooxygenase [COX] 2 inhibitorsfor gastrointestinal disorders ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-7001895-B2 Prostaglandin endoperoxide H synthase biosynthesis inhibitors ABBOTT LABORATORIES (US) 2006-02-21 US disclosed
US-20030225276-A1 Prostaglandin endoperoxide H synthase biosynthesis inhibitors BLACK LAWRENCE A (US) 2003-12-04 US disclosed
US-20020028938-A1 Prostaglandin endoperoxide H synthase biosynthesis inhibitors BLACK LAWRENCE A (US) 2002-03-07 US disclosed
US-20020013318-A1 Prostaglandin endoperoxide H synthase biosynthesis inhibitors BLACK LAWRENCE A (US) 2002-01-31 US disclosed
US-6307047-B1 PYRIDAZINONE COMPOUNDS; INHIBITORS OF CYCLOOXYGENASE-2 (COX-2); SELECTIVITY OF THESE COMPOUNDS FOR COX-2 MINIMIZES THE UNWANTED GI AND RENAL SIDE-EFFECTS SEEN WITH CURRENTLY MARKETED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ABBOTT LABORATORIES 2001-10-23 US disclosed
EP-1124804-A1 PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS ABBOTT LABORATORIES (US) 2001-08-22 EP disclosed
WO-2000024719-A1 PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS ABBOTT LABORATORIES (US) 2000-05-04 WO disclosed
JP-S606651-A 1-HYDROXY-2-HYDROXYDIAZENIUMOXYDYLPROPANE AND ITS SALT OJI KOONSUTAAC KK 1985-01-14 JP disclosed
US-4338451-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1982-07-06 US disclosed
US-4250318-A ANTIDEPRESSANTS DELALANDE S.A. (FR) 1981-02-10 US disclosed